XML 146 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock Compensation Plans and Other Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Summary of Stock Option Activity
A summary of the Plans’ stock option activity for the years ended December 31, 2019, 2018 and 2017 is as follows:
Stock Options
 
Common
Shares
 
Weighted Average
Strike Price
 
Remaining
Contractual Term(1)
 
Intrinsic Value(2)
($000)
Outstanding at January 1, 2017
 
1,698,912

 
$
41.50

 
 
 
 
Granted
 

 

 
 
 
 
Exercised
 
(593,459
)
 
40.57

 
 
 
 
Forfeited or canceled
 
(20,697
)
 
42.83

 
 
 
 
Outstanding at December 31, 2017
 
1,084,756

 
$
41.98

 
4.0
 
$
43,817

Exercisable at December 31, 2017
 
562,810

 
$
41.82

 
3.3
 
$
22,820

Outstanding at January 1, 2018
 
1,084,756

 
$
41.98

 
 
 
 
Granted
 

 

 
 
 
 
Exercised
 
(282,614
)
 
41.25

 
 
 
 
Forfeited or canceled
 
(7,128
)
 
39.84

 
 
 
 
Outstanding at December 31, 2018
 
795,014

 
$
42.25

 
3.1
 
$
19,268

Exercisable at December 31, 2018
 
613,932

 
$
42.54

 
3.1
 
$
14,705

Outstanding at January 1, 2019
 
795,014

 
$
42.25

 
 
 
 
Granted
 

 

 
 
 
 
Options outstanding in acquired plans
 
106,748

 
38.83

 
 
 
 
Exercised
 
(146,430
)
 
38.84

 
 
 
 
Forfeited or canceled
 

 

 
 
 
 
Outstanding at December 31, 2019
 
755,332

 
$
42.43

 
2.8
 
$
21,503

Exercisable at December 31, 2019
 
735,396

 
$
42.42

 
2.7
 
$
20,947

Vested or expected to vest at December 31, 2019
 
755,332

 
$
42.43

 
2.8
 
$
21,503


(1)
Represents the weighted average contractual remaining life in years.
(2)
Aggregate intrinsic value represents the total pretax intrinsic value (i.e., the difference between the Company’s stock price at year end and the option exercise price, multiplied by the number of shares) that would have been received by the option holders if they had exercised their options on the last day of the year. Options with exercise prices above the year end stock price are excluded from the calculation of intrinsic value. The intrinsic value will change based on the fair market value of the Company’s stock.
Summary of Plans' Restricted Share Award Activity
A summary of the Plans’ restricted share activity for the years ended December 31, 2019, 2018 and 2017 is as follows:
 
 
 
2019
 
2018
 
2017
Restricted Shares
 
Common
Shares
 
Weighted
Average
Grant-Date
Fair Value
 
Common
Shares
 
Weighted
Average
Grant-Date
Fair Value
 
Common
Shares
 
Weighted
Average
Grant-Date
Fair Value
Outstanding at January 1
 
143,263

 
$
60.80

 
127,787

 
$
53.33

 
133,425

 
$
49.94

Granted
 
24,285

 
68.58

 
35,654

 
84.36

 
16,552

 
73.16

Vested and issued
 
(21,529
)
 
70.99

 
(18,324
)
 
54.31

 
(19,639
)
 
47.13

Forfeited or canceled
 
(1,691
)
 
79.50

 
(1,854
)
 
63.50

 
(2,551
)
 
52.26

Outstanding at end of year
 
144,328

 
$
60.37

 
143,263

 
$
60.80

 
127,787

 
$
53.33

Vested, but not issuable at end of year
 
92,183

 
$
52.24

 
90,520

 
$
51.94

 
89,723

 
$
51.64



A summary of the Plans’ performance-based stock award activity, based on the target level of the awards, for the years ended December 31, 2019, 2018 and 2017 is as follows:
 
 
2019
 
2018
 
2017
Performance Shares
 
Common
Shares
 
Weighted
Average
Grant-Date
Fair Value
 
Common
Shares
 
Weighted
Average
Grant-Date
Fair Value
 
Common
Shares
 
Weighted
Average
Grant-Date
Fair Value
Outstanding at January 1
 
396,855

 
$
67.71

 
359,196

 
$
54.37

 
298,180

 
$
43.64

Granted
 
175,823

 
71.56

 
134,380

 
88.27

 
145,853

 
72.60

Added by performance factor at vesting
 
33,950

 
40.99

 

 

 

 

Vested and issued
 
(128,238
)
 
41.00

 
(82,307
)
 
44.39

 
(68,712
)
 
46.85

Forfeited or canceled
 
(12,875
)
 
75.08

 
(14,414
)
 
60.05

 
(16,125
)
 
52.98

Outstanding at end of year
 
465,515

 
$
74.37

 
396,855

 
$
67.71

 
359,196

 
$
54.37

Vested, but deferred at year end
 
33,828

 
$
43.01

 
21,530

 
$
43.54

 
108,143

 
$
44.16